WallStreetZenWallStreetZen

NASDAQ: OCUL
Ocular Therapeutix Inc Stock Ownership - Who owns Ocular Therapeutix?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ocular Therapeutix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nadia WaheedChief Medical Officer2025-06-0213,861$8.05
$111.58kSell
Peter KaiserChief Development Officer2025-05-232,974$7.17
$21.32kSell
Pravin DugelExecutive Chairman President and CEO2025-05-2321,219$7.18
$152.35kSell
Jeffrey S. HeierChief Scientific Officer2025-05-233,024$7.18
$21.71kSell
Sanjay NayakChief Strategy Officer2025-05-231,862$7.17
$13.35kSell
Richard L. Md LindstromDirector2025-05-0810,000$6.96
$69.60kBuy
Sanjay NayakChief Strategy Officer2025-02-241,895$6.84
$12.96kSell
Peter KaiserChief Development Officer2025-02-243,009$6.87
$20.67kSell
Jeffrey S. HeierChief Scientific Officer2025-02-243,061$6.87
$21.03kSell
Pravin DugelExecutive Chairman President and CEO2025-02-2421,475$6.87
$147.53kSell

1 of 2

OCUL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OCUL insiders and whales buy or sell their stock.

OCUL Shareholders

What type of owners hold Ocular Therapeutix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Deep Track Capital LP8.97%14,294,420$166.67MInstitution
Summer Road LLC8.71%13,878,018$161.82MInstitution
Vr Adviser LLC8.01%12,762,462$148.81MInstitution
Blackrock Inc7.54%12,012,397$140.06MInstitution
Opaleye Management Inc6.41%10,213,500$119.09MInsider
Summer Road LLC5.39%8,591,401$100.18MInsider
Vanguard Group Inc5.25%8,364,515$97.53MInstitution
Avoro Capital Advisors LLC5.06%8,060,000$93.98MInstitution
Tcg Crossover Management LLC3.34%5,319,148$62.02MInstitution
Adage Capital Partners GP LLC3.26%5,200,000$60.63MInstitution

1 of 3

OCUL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OCUL78.93%21.07%Net SellingNet Selling
FOLD65.78%34.22%Net Selling
VCYT66.43%33.57%Net SellingNet Selling
VCEL91.20%8.80%Net SellingNet Buying
MESO0.33%0.00%
View Top Biotech Stocks

Ocular Therapeutix Stock Ownership FAQ

Who owns Ocular Therapeutix?

Ocular Therapeutix (NASDAQ: OCUL) is owned by 86.23% institutional shareholders, 23.01% Ocular Therapeutix insiders, and 0.00% retail investors. Opaleye Management Inc is the largest individual Ocular Therapeutix shareholder, owning 10.21M shares representing 6.41% of the company. Opaleye Management Inc's Ocular Therapeutix shares are currently valued at $118.27M.

If you're new to stock investing, here's how to buy Ocular Therapeutix stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.